CNJYAB,a new force in the pharmaceutical industry, was founded in May 2010. Its main business covers the drug discovery, drug development services, computer auxiliary, database development, network and medical information systems development etc. The company focuses on the drug discovery and drug development services, designing and building a multi-dimensional matrix molecule design platform (MDMMDP) with independent intellectual property rights, which fills the gaps of the drug discovery platforms for molecule design worldwide. With the support of the platform, the company designs and produces the pharmaceutical chemical reagents, drug-like chemicals including new drugs. Moreover, the company develops and utilizes the downstream projects like the database development and web-based services with the support of a self-developed software built-in with molecular structure search function.